Ionis Pharmaceuticals, Inc. (IONS)

80.33 -1.01 (-1.24%) USD  |  NASDAQ  |  Dec 23, 16:00
81.57 +1.24 (+1.54%) Pre-Market: 08:51
More

Ionis Pharmaceuticals SG&A Expense (TTM): 351.68M for Sept. 30, 2025

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for IONS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Merck & Co., Inc. 10.70B
Pfizer Inc. 13.91B
Biogen, Inc. 2.431B
Eli Lilly & Co. 10.39B
Cogent Biosciences, Inc. 51.34M